Intracellular Polymerization

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  1989-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1749-6632.1989.tb24152.xPMID 2476066
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experience.

  1989cited by this paper
• Analyses of linked beta-globin genes suggest that nondeletion forms of hereditary persistence of fetal hemoglobin are bona fide switching mutants.

  1988cited by this paper
• Levels of fetal hemoglobin necessary for treatment of sickle cell disease.

  1988cited by this paper
• Fetal hemoglobin levels and beta (s) globin haplotypes in an Indian populations with sickle cell disease.

  1987cited by this paper
• Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo.

  1987cited by this paper
• Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia.

  1987cited by this paper
• Clinical and molecular correlations in the sickle/β+‐thalassemia syndrome

  1987cited by this paper
• Molecular analysis of the high-hemoglobin-F phenotype in Saudi Arabian sickle cell anemia.

  1987cited by this paper
• Hemoglobin as a receptor of drugs and peptides: x-ray studies of the stereochemistry of binding

  1986cited by this paper
• Kinetics of sickle hemoglobin polymerization. II. A double nucleation mechanism.

  1985cited by this paper
• Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.

  1985cited by this paper
• Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients.

  1985cited by this paper
• Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes.

  1985cited by this paper
• Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia?

  1984cited by this paper
• Polymerization in erythrocytes containing S and non-S hemoglobins.

  1984cited by this paper
• Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia.

  1984cited by this paper
• Production of F cells in sickle cell anemia: regulation by a genetic locus or loci separate from the beta-globin gene cluster.

  1984cited by this paper
• Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia

  1984cited by this paper
• 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia

  1983cited by this paper
• Intracellular polymerization of sickle hemoglobin. Effects of cell heterogeneity.

  1983cited by this paper
• alpha-Thalassemia reduces the hemolytic rate in homozygous sickle-cell disease.

  1983cited by this paper
• alpha-Thalassemia reduces the hemolytic rate in homozygous sickle-cell disease.

  1983cited by this paper
• Comparative evaluation of fifteen anti-sickling agents.

  1983cited by this paper
• 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia.

  1983cited by this paper
• Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.

  1982cited by this paper
• The interaction of alpha-thalassemia and homozygous sickle-cell disease.

  1982cited by this paper
• Molecular and cellular pathogenesis of hemoglobin SC disease.

  1982cited by this paper
• Refined crystal structure of deoxyhemoglobin S. I. Restrained least-squares refinement at 3.0-A resolution.

  1982cited by this paper
• Concurrent Sickle-Cell Anemia and α-Thalassemia: Effect on Severity of Anemia

  1982cited by this paper
• Molecular topology in crystals and fibers of hemoglobin S.

  1981cited by this paper
• Determination of deoxyhemoglobin S polymer in sickle erythrocytes upon deoxygenation.

  1980cited by this paper
• Hb F Synthesis in Sickle Cell Anaemia: a Comparison of Saudi Arab Cases with those of African Origin

  1980cited by this paper
• A study of induced hyponatremia in the prevention and treatment of sickle-cell crisis.

  1980cited by this paper
• Comparison of Sickle Cell‐β° Thalassaemia with Homozygous Sickle Cell Disease

  1979cited by this paper
• Gelation of sickle cell hemoglobin in mixtures with normal adult and fetal hemoglobins.

  1979cited by this paper
• Comparison of sickle cell-beta0 thalassaemia with homozygous sickle cell disease.

  1979cited by this paper
• Sickle cell anemia and trait in Southern India: Further studies

  1979cited by this paper
• Requirements for therapeutic inhibition of sickle haemoglobin gelation

  1978cited by this paper
• Inhibition of sickle hemoglobin gelation by amino acids and related compounds.

  1978cited by this paper
• Studies on the mechanism of action of cyanate in sickle cell disease. Oxygen affinity and gelling properties of hemoglobin S carbamylated on specific chains.

  1974cited by this paper
• RATE OF SICKLING OF RED CELLS DURING DEOXYGENATION OF BLOOD FROM PERSONS WITH VARIOUS SICKLING DISORDERS.

  1964cited by this paper

• Microfluidic Methods to Advance Mechanistic Understanding and Translational Research in Sickle Cell Disease.

  2022cites this paper
• Preliminary Evaluation of the Anti-sickling and Polymerization Time Rate of Aqueous Extracts of Beta Vulgaris (Beetroot) on Sickle Cell Disorder (In-vitro model)

  2022cites this paper
• Sickle cell vaso-occlusion: The dialectic between red cells and white cells

  2021cites this paper
• Fetal hemoglobin rescues ineffective erythropoiesis in sickle cell disease

  2020cites this paper
• Nitric oxide pathology and therapeutics in sickle cell disease

  2018cites this paper
• Potential of Three Ethnomedicinal Plants as Antisickling Agents.

  2017cites this paper
• Low fetal hemoglobin percentage is associated with silent brain lesions in adults with homozygous sickle cell disease.

  2017cites this paper
• dehydration in vitro and in vivo in SAD mice ICA-17043, a novel Gardos channel blocker, prevents sickle red blood cell

  2013cites this paper
• Disorders of Hemoglobin: THE MOLECULAR, CELLULAR, AND GENETIC BASIS OF HEMOGLOBIN DISORDERS

  2009cites this paper
• Disorders of hemoglobin: Genetics, pathophysiology, and clinical management, second edition

  2009cites this paper
• Universal metastability of sickle hemoglobin polymerization.

  2008cites this paper
• ANTISICKLING AND TOXICOLOGICAL PROPERTIES OF THIOCYANATE, TELLURITE AND HYDROXYUREA: IN VITRO AND IN VIVO STUDIES

  2007cites this paper
• Chaperone and anti‐chaperone: Two‐faced synuclein as stimulator of synaptic evolution

  2006cites this paper
• Oxidant, Hemolytic and Inflammatory Stress of Sickle Cell Disease Blood Mononuclear Cell Gene Expression Profiles Characterize the

  2004cites this paper
• Hyperoxia during recovery from consecutive anaerobic exercises in the sickle cell trait

  2004cites this paper
• Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease.

  2004cites this paper
• Established and experimental treatments for sickle cell disease.

  2004cites this paper
• ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice.

  2003cites this paper
• Sickle Cell Disease

  2003cites this paper
• 23 Sickle Cell Disease

  2003cites this paper
• Development of new treatments for Parkinson's disease in transgenic animal models: a role for beta-synuclein.

  2002cites this paper
• Development of sensitive fluorescent assays for embryonic and fetal hemoglobin inducers using the human beta -globin locus in erythropoietic cells.

  2002cites this paper
• Modification of erythrocyte hydration in the treatment of sickle cell disease.

  2001cites this paper
• beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor.

  2001cites this paper
• Red cell adhesion molecules, foetal haemoglobin and endothelial factors in sickle cell disorders

  2001cites this paper
• Erythrocyte-active agents and treatment of sickle cell disease.

  2001cites this paper
• β-Synuclein Inhibits α-Synuclein Aggregation: A Possible Role as an Anti-Parkinsonian Factor

  2001cites this paper
• Oral magnesium pidolate: effects of long‐term administration in patients with sickle cell disease

  2000cites this paper
• Formation of dense erythrocytes in SAD mice exposed to chronic hypoxia: evaluation of different therapeutic regimens and of a combination of oral clotrimazole and magnesium therapies.

  1999cites this paper
• Slow and Steady Wins The Race? Progress in the Development of Vectors for Gene Therapy of β-Thalassemia and Sickle Cell Disease.

  1999cites this paper
• Red blood cell indices, cation content, and membrane cation transports.

  1998cites this paper
• Intracellular hemoglobin S polymerization and the clinical severity of sickle cell anemia.

  1998cites this paper
• Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease.

  1997cites this paper
• Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo.

  1997cites this paper
• Relationship between genotype and phenotype in monogenic diseases: Relevance to polygenic diseases

  1996cites this paper
• Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disease.

  1994cites this paper
• Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells

  1994cites this paper
• Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells.

  1994cites this paper
• 3 Sickle cell disease pathophysiology

  1993cites this paper
• Sickle cell disease pathophysiology.

  1993cites this paper
• Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations.

  1993cites this paper
• Beta s-gene-cluster haplotypes in sickle cell anemia. Clinical and hematologic features.

  1991cites this paper